S&P/ASX 200 Index (ASX: XJO) shares are down 0.7% to 8,726.2 points on Thursday.

Here at The Fool, we’ve been super busy analysing the market’s performance over FY26.

You might like to check out the 13 ASX 200 shares that doubled (or better) in value last year.

Or the best and worst-performing ASX 200 sectors. Or the No. 1 stock for capital growth in each sector.

In this article, we look ahead to FY27.

Experts reckon these ASX 200 shares could be in for an exceptional period of growth in the new financial year.

Here’s why.

Mesoblast Ltd (ASX: MSB) 

The Mesoblast share price rose by a very respectable 18% in FY26 to finish at $1.96 on 30 June. 

Bell Potter reiterated its speculative buy rating last week with an unchanged target of $4.45. 

This implies the Mesoblast share price could more than double over the next 12 months. 

The broker said: 

The key overhang on the stock remains clinical trial risk with three massive valuation events over the next 18 months being adult GvHD, back pain and the BLA approval for the first indication in HF.

None of these are priced in.

The broker added:

The recent clinical trial fail by Cynata and its MSC in adult GvHD highlights yet again the risks involved in drug development.

MSB will shortly enrol the first of 180 patients in its randomised, controlled, double blind label expansion study for Ryoncil, also in adult GvHD, albeit with risk of failure mitigated by numerous factors.

These factors include a tried and tested potency assay, more aggressive dose (up to 300% higher than the Cynata product) and a 2nd line patient population that has progressed following steroid therapy.

Judo Capital Holdings Ltd (ASX: JDO)

The Judo share price fell 40% in FY26 to finish at 94 cents.

Judo was smashed in the final month of FY26 after downgrading its profit guidance.

Morgans renewed its buy rating on the ASX 200 bank share with a drastic cut to its price target, which is now $1.47.

This implies the broker is confident of a strong bounce back of at least 55% over the next year.

Morgans said:

The share price drawdown was vicious (particularly considering the decline that had already occurred since February).

While the earnings growth outlook has moderated, we still forecast c.30% EPS growth across both FY26 and FY27 with the stock now trading on a c.6.8x PER (FY27F) and 0.6x P:BV (end-FY26).

A significant risk premium or probability of failure has been priced into the stock. BUY.

Zip Co Ltd (ASX: ZIP)

The Zip share price rose 5.5% to close out FY26 at $3.24 on 30 June.  

Jonathon Higgins from United Capital Partners (UCPS) says Zip shares are a buy for FY27.

Higgins is impressed with the buy now, pay later company’s turnaround.

In a note, Higgins said Zip was on track to report annual cash earnings of more than $260 million just three years after a $50 million loss. 

Higgins says the market is underappreciating Zip’s cost discipline and its growth prospects in the US.

UCPS has a 12-month target of $4.85. This implies a possible 50% upside over the next year.

Higgins said:

Sustainable earnings momentum against structural growth is hard to find on the ASX currently. 

The post 3 ASX 200 shares with 50% to 100% upside in FY27 appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: CAR Group, Judo Capital, and Worley shares
• Forget CBA shares, I’d buy these ASX bank stocks instead
• 2 ASX 200 healthcare shares to buy after sector rebounds 23% in a month
• Judo Bank shares rise despite Morgan Stanley price target cut
• Down 35%+, should you buy Zip and WiseTech shares?

Motley Fool contributor Bronwyn Allen has positions in Zip Co. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

After a huge 12-month run, Cobre Ltd (ASX: CBE) shareholders are seeing some selling pressure on Wednesday.

The ASX copper stock has returned from a trading halt, and investors have not exactly rushed back in.

At the time of writing, the Cobre share price is down 10.61% to 29.5 cents.

Even after today’s fall, Cobre shares are still up 195% since the start of 2026 and around 640% over the past year.

Here’s what the company revealed.

$90 million placement completed

According to the release, Cobre has received firm commitments to raise $90 million before costs through a two-tranche placement.

The company will issue around 300 million new shares at 30 cents each to institutional, sophisticated, and professional investors.

The first tranche is expected to raise about $72 million, while the second tranche is expected to raise a further $18 million.

However, the second tranche will need shareholder approval at an extraordinary general meeting, which is expected to be held in late August or early September.

Cobre said the raising was strongly supported by new and existing shareholders, including global resources specialists and domestic and offshore investors.

Two of its major shareholders, Tribeca Investment Partners and Strata Investment Holdings, helped cornerstone the raising.

Cobre directors are also planning to take part, with board members committing a combined $200,000, subject to shareholder approval.

Where the money is going

A big chunk of the raising is being directed towards Cobre’s Sierra Atacama Copper Project in Chile.

Cobre said the money will go towards increasing its stake in the project, repaying debt, upgrading the plant, and funding more drilling.

The company has set aside $29 million for plant upgrades and other development costs at Sierra Atacama.

Another $26 million is expected to go towards debt repayment, while $17 million will be used to increase Cobre’s ownership in the project.

Cobre also plans to spend $17 million on Sierra Atacama exploration, including resource, near-mine, and high-grade sulphide drilling.

Why are Cobre shares falling?

The selling pressure appears to be coming from the terms of the capital raising.

Cobre priced the placement at 30 cents per share, which is a 9.1% discount to its last close of 33 cents on 6 July. It is also below the 10-day volume weighted average price of 32.8 cents.

Furthermore, the raising will add a large number of new shares.

If both tranches are completed, Cobre will issue around 300 million new shares, adding to the 966 million shares it already has on issue.

After such a strong run over the past year, the discounted placement and extra shares were always going to weigh on the stock.

The next things to watch are the shareholder vote on the second tranche and the next round of work at Sierra Atacama.

The post This ASX stock is tumbling 10% after huge 640% run. Here’s why appeared first on The Motley Fool Australia.

More reading

• 3 ASX 200 shares with 50% to 100% upside in FY27
• QBE shares rebound 35% to fresh multi-year high: Buy, sell or hold?
• Why are Fletcher Building shares flying 7% higher today?
• Takeover talk and a boardroom shake-up: Why Northern Star shares are falling today
• Average superannuation balance for 58 year olds in Australia. How does yours compare?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

QBE Insurance Group Ltd (ASX: QBE) shares have climbed higher into the green in Thursday morning trade.

At the time of writing, the shares are up around 0.5% and changing hands at $25.49 a piece. At one point this morning, the shares were as high as $25.52.

The current trading price is the highest level seen since early 2009.

QBE shares had a slow start to the year after dropping to a low of $18.83 in December. The shares have rebounded 35% from that dip and are now up around 29% for the year to date and 12% higher than this time last year.

What has driven the QBE share price rebound in 2026?

QBE shares have rebounded off the back of support from stronger insurance earnings and higher premiums.

In May, the company posted its first-quarter FY26 update. It revealed an 11% year-on-year increase in gross written premium (GWP), or 7% on a constant currency basis. 

The insurer also reported total funds under management of $36.1 billion at the end of the quarter.

QBE maintained its FY26 outlook, pointing to mid-single-digit gross written premium growth and a group combined operating ratio of around 92.5%.

Then, just yesterday, the company announced a senior leadership change. In a statement to the ASX, QBE said Sue Houghton will step down from her role as Chief Executive Officer for Australia Pacific at the end of 2026. The move hasn’t seemed to spook investors, and the company’s share price has continued rallying higher.

Are the shares a buy, sell, or hold now?

The experts are divided about the outlook for QBE shares over the next 12 months.

Market Index data shows that around half of brokers have a buy rating on the shares. But the $23.35 average target price currently implies a potential 8% downside ahead.

Sentiment is a little more bullish on TradingView data. Out of 11 analysts, six have a buy or strong buy rating on the shares. Another two rate QBE as a hold, and three have a sell stance.

But the average $24.52 target price also implies a 4% downside at the time of writing, likely due to the latest share price rally.

Some are more optimistic, though, and think QBE shares have the potential to climb another 9% to $27.62 a piece.

Investment firm Market Partners is positive on the outlook for QBE shares and sees an emerging turnaround story ahead. It recently noted that QBE has been working hard to simplify its business over the past 5 to 10 years, including a number of acquisitions, and it’s now paying off. 

The post QBE shares rebound 35% to fresh multi-year high: Buy, sell or hold? appeared first on The Motley Fool Australia.

More reading

• QBE shares surge again as $37 billion insurance giant faces leadership change
• 3 ASX 200 shares to buy now: experts
• QBE shares soar to fresh multi-year high: Here’s what brokers expect next
• Invested in ASX 200 bank shares for dividends? This fundie prefers other stocks
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.